Evidence map›Paper›PMID 21602824›Full record

ArticleNature2011

Detection of prokaryotic mRNA signifies microbial viability and promotes immunity.

Leif E Sander, Michael J Davis, Mark V Boekschoten, Derk Amsen, Christopher C Dascher, Bernard Ryffel, Joel A Swanson, Michael Müller, J Magarian Blander

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Nature, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 246 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
246citing papers in PubMed, 1 pooled it
17.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

246 citing papers in PubMed, 1 synthesis or guideline pooled it, 401 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. An overview of human inflammasomes: Activation and regulation.Journal of immunology (Baltimore, Md. : 1950) · 2026
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Innate detection ofbioRxiv : the preprint server for biology · 2025
    Article
  17. Single-cell quantification of the microbiota by flow cytometry: MicFLY.bioRxiv : the preprint server for biology · 2025
    Article
  18. Article
  19. Review
  20. Article

186 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Leif E SanderImmunology Institute, Department of Medicine, Mount Sinai School of Medicine, 1425 Madison Avenue, New York, New York 10029, USA.
Michael J Davis
Mark V Boekschoten
Derk Amsen
Christopher C Dascher
Bernard Ryffel
Joel A Swanson
Michael Müller
J Magarian Blander
Icahn School of Medicine at Mount Sinai · USUniversity of Michigan–Ann Arbor · USWageningen University & Research · NLAcademic Medical Center · NLUniversité d'Orléans · FR

Funding

Cellular Biotechnology Training Program (CBTP) - Years 31-35T32GM145304 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Guizhi Zhu · 2022 to 2026
$2.6M
Control of protective immunity by innate pathways sensing bacterial viabilityR01AI095245 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BLANDER, JULIE MAGARIAN · 2012 to 2015
$1.7M
Coordination of signaling during phagocytosisR01AI064668 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SWANSON, JOEL A · 2005 to 2010
$1.6M
Innate Immune Sensing of Microbial ViabilityR21AI080959 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BLANDER, JULIE MAGARIAN · 2009 to 2010
$466k
NIAID NIH HHS AI080959ANIAID NIH HHS R01 AI064668NIAID NIH HHS R01 AI095245NIAID NIH HHS R21 AI080959NIGMS NIH HHS T32 GM145304
6 · The paper itself

Abstract

Live vaccines have long been known to trigger far more vigorous immune responses than their killed counterparts. This has been attributed to the ability of live microorganisms to replicate and express specialized virulence factors that facilitate invasion and infection of their hosts. However, protective immunization can often be achieved with a single injection of live, but not dead, attenuated microorganisms stripped of their virulence factors. Pathogen-associated molecular patterns (PAMPs), which are detected by the immune system, are present in both live and killed vaccines, indicating that certain poorly characterized aspects of live microorganisms, not incorporated in dead vaccines, are particularly effective at inducing protective immunity. Here we show that the mammalian innate immune system can directly sense microbial viability through detection of a special class of viability-associated PAMPs (vita-PAMPs). We identify prokaryotic messenger RNA as a vita-PAMP present only in viable bacteria, the recognition of which elicits a unique innate response and a robust adaptive antibody response. Notably, the innate response evoked by viability and prokaryotic mRNA was thus far considered to be reserved for pathogenic bacteria, but we show that even non-pathogenic bacteria in sterile tissues can trigger similar responses, provided that they are alive. Thus, the immune system actively gauges the infectious risk by searching PAMPs for signatures of microbial life and thus infectivity. Detection of vita-PAMPs triggers a state of alert not warranted for dead bacteria. Vaccine formulations that incorporate vita-PAMPs could thus combine the superior protection of live vaccines with the safety of dead vaccines.

Indexed as

Adaptor Proteins, Vesicular TransportAnimalsAntibodies, BacterialBacteriaBacterial VaccinesCarrier ProteinsCells, CulturedDendritic CellsImmunity, InnateInflammasomesInterferon-betaMacrophagesMiceMice, Inbred C57BLMicrobial ViabilityNLR Family, Pyrin Domain-Containing 3 ProteinAdaptor Proteins, Vesicular TransportAntibodies, BacterialBacterial VaccinesCarrier ProteinsInflammasomesInterferon-betaNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, mouseRNA, BacterialRNA, MessengerTicam1 protein, mouseVaccines, AttenuatedVaccines, InactivatedVirulence Factors

Identifiers

PMID21602824
PMCPMC3289942
OpenAlexW2097072854

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.